TOL101

From WikiMD's Wellness Encyclopedia

TOL101 is an investigational immunotherapy drug that is currently being studied for its potential use in the prevention of organ transplant rejection. It is a monoclonal antibody that targets the alpha-beta T-cell receptor, which plays a crucial role in the immune response.

Mechanism of Action[edit | edit source]

TOL101 works by binding to the alpha-beta T-cell receptor on the surface of T cells. This prevents the T cells from recognizing and attacking the transplanted organ, thereby reducing the risk of organ rejection.

Clinical Trials[edit | edit source]

Several clinical trials have been conducted to evaluate the safety and efficacy of TOL101. These trials have shown promising results, with TOL101 demonstrating a good safety profile and potential efficacy in preventing organ rejection.

Potential Applications[edit | edit source]

If approved, TOL101 could be used in combination with other immunosuppressive drugs to prevent organ rejection in transplant patients. It could potentially improve the outcomes of organ transplants by reducing the risk of rejection and the associated complications.

See Also[edit | edit source]

References[edit | edit source]


TOL101 Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD